A
Aptevo Therapeutics Inc. (APVO)
NCM – Real Time Price. Currency in USD
4.55
-0.03 (-0.66%)
At close: Jun 26, 2026, 4:00 PM EDT
4.55
-0.00 (-0.02%)
After-hours: Jun 26, 2026, 4:14 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
4.55
-0.03 (-0.66%)
At close: Jun 26, 2026, 4:00 PM EDT
4.55
-0.00 (-0.02%)
After-hours: Jun 26, 2026, 4:14 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $14.5M significantly exceed its total debt $4.4M, ensuring strong financial flexibility
Total current assets $16.0M exceed Total current liabilities $4.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.4) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$8.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.36 | 6.05 | 10 | |
| Quick ratio | 3.36 | 5.63 | 10 | |
| Debt to Equity | 0.38 | 0.30 | 7.0 | |
| Debt to Assets | 0.22 | 1.04 | 7.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 3M | N/A | N/A | N/A | N/A |
| Gross Profit | 2M | -567K | -352K | -240K | -214K |
| Operating Income | -29M | -29M | -25M | -26M | -27M |
| Net Income | 8M | -17M | -24M | -26M | -28M |
| EBITDA | -28M | -28M | -24M | -26M | -26M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 96.02 | 5.5 |
| Next quarter | N/A | 85.87 | 5.5 |
| Current year | N/A | 73.24 | 5.5 |
| Next year | N/A | 48.09 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -17.01 | -100.37 | -52.11 | 3.3 |
| Y/Y | 999 | -6.01 | 99.59 | -21.13 | 5.5 |
| 3y average | 632.67 | -121.02 | -19.23 | -22.01 | 3.3 |
| 5y average | 401.72 | -44.7 | 19.08 | -7.24 | 5.3 |
| Weighted average score | 4.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |